- Home
- » Tags
- » Cericlamine
Top View
- Template for Electronic Submission to ACS Journals
- Use of Combinations Comprising a Corticosteroid and a Pyrimidopyrimidine in the Treatment of Inflammatory Diseases
- Customs Tariff - Schedule
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- Pharmaabkommen A1 E
- Premenstrual Dysphoric Disorder Or Pmdd).Mp
- Customs Tariff - Schedule Xxi - 1
- Wo 2007/044693 A2
- Harmonized Tariff Schedule of the United States (2006) (Rev
- Customs Tariff - Schedule Xxi - 1
- United States Patent (19) 11 Patent Number: 5,977,099 Nickolson (45) Date of Patent: Nov
- CANADIAN PATENTEES and PATENTED DRUG PRODUCTS for HUMAN USE JANUARY 1 – DECEMBER 31, 2007 DIN/GP Brand Name Generic Name ATC Dosage Form Comments Status
- WO 2016/135707 Al 1 September 2016 (01.09.2016) P O P C T
- Pipamperone and a Second Agent in Treating Mood and Anxiety Disorders
- The Effects of LPM570065, a Novel Triple Reuptake Inhibitor, on Extracellular Serotonin, Dopamine and Norepinephrine Levels in Rats
- Association of Sleep Architecture and Physiology with Depressive Disorder and Antidepressants Treatment
- (12) United States Patent (10) Patent No.: US 9,439,907 B2 Hale Et Al
- L:\0900\0900PHARMAPPX .Wpd
- Sleep Neurobiology from a Clinical Perspective
- Schedule Clxxiii - European Union
- 5-HT1A/1B Receptor-Mediated Effects of the Selective Serotonin Reuptake Inhibitor, Citalopram, on Sleep: Studies in 5-HT1A and 5-HT1B Knockout Mice
- INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
- WO 2007/016766 Al
- %2D2L:Sssxsxxxxxxx Xxyyxx.Ass